Omri joined Qumra Capital in November 2021 as Director & Head of Qumra Opportunity Fund.
Omri brings over 10 years of investment experience in venture capital, growth equity and private equity as well as M&A deal execution across multiple industries. Prior to joining Qumra, Omri was a Principal at aMoon Growth, Israel’s largest healthcare and life sciences venture capital fund. At aMoon Omri led deal execution, diligence and portfolio work and served on the boards of MiNA Therapeutics, Viracta Therapeutics, and Cartiheal. Prior to aMoon, Omri was an investment professional at Apax Partners, where he worked on a number of cross-border and Israeli-related transactions. Omri’s deal experience includes Global-e (NASDAQ: GLBE), Max, Ultima Genomics, Seer (NASDAQ: SEER), and Cartiheal, among others. Omri began his career as an investment banker with Bank of America Merrill Lynch in New York and London, where he specialized in advising corporate clients on mergers and acquisitions and capital markets transactions.
Omri holds a BA, with High Honors, in Economics and Psychology from Brandeis University.
In this newsletter you can expect to receive Qumra's perspective on the market trends and developments. Something you won’t want to miss! Keep an eye on your inbox, coming soon…